openPR Logo
Press release

USD 26.78 billion worth is expected for Active Implantable Medical Devices Market by 2021

11-29-2017 08:30 AM CET | Health & Medicine

Press release from: MDF

USD 26.78 billion worth is expected for Active Implantable

The global Active Implantable Medical Devices market is anticipated to grow at a 7.76% CAGR from 2016 to 2021 and it is estimated that the global market was valued at USD 18.43 billion in 2016 and is expected to reach USD 26.78 billion by 2021.

Browse details of 185 pages research report on Active Implantable Medical Devices market @ http://www.marketdataforecast.com/market-reports/active-implantable-medical-devices-market-5027/

Active Implantable Medical Devices Market Overview:
The Active Implantable Medical Device (AIMD) Directive 90/385/EEC defines an active implantable medical device as "any active medical device which is intended to be totally or partially introduced, surgically or medically, into the human body or by medical intervention into a natural orifice, and which is intended to remain after the procedure". As one of the highest risk categories of device, they are subject to severe regulatory controls both pre- and post-market. The regulatory controls set out in the AIMD Directive also apply to any accessories that are used to enable the device to operate as intended, for examples leads, programmers, controllers, battery packs, software applications, implant kits and refill kits.

The demand for active implantable medical devices is rising due to increase in the prevalence of cardiovascular diseases and increase in the incidences of neurological disorders. Cardiovascular disease is the leading cause of premature death around the world. Implantable cardioverter defibrillators and implantable cardiac pacemakers are the main medical devices used for the treatment of different cardiovascular conditions. High prevalence of cardiovascular diseases depicts an increase in the demand for these devices. According to the World Health Organization WHO, globally, around 17.5 million people died due to cardiovascular diseases in 2012, while the number is anticipated to reach 23.3 million by 2030. Factors such as advancement in technological, increase in the prevalence of cardiovascular diseases, rise in the healthcare expenditures by patients and increase in the research and development activities are the major factors driving the growth of the global active implantable medical devices market. However, the high cost of implantable medical devices and unfavorable reimbursement guidelines pose crucial challenge thereby limiting the adoption of active implantable medical devices solutions.

Avail Sample Market Brochure of the report for more information, Get a Copy @ http://www.marketdataforecast.com/market-reports/active-implantable-medical-devices-market-5027/request-sample

Active Implantable Medical Devices Market Segmentation:
The global market for Active Implantable Medical Devices market is segmented into Product and Region. On the basis of Product, it is segmented into Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator and Implantable Hearing Devices. Cardioverter defibrillators held the largest share in the active implantable medical devices market in 2016, due to the increase in the prevalence of cardiovascular diseases and high compliance for technologically advanced products. Transvenous implantable cardioverter desfibrillator which is further segmented into biventricular implantable cardioverter defibrillators, dual-chamber implantable cardioverter defibrillators. Single-chamber implantable cardioverter defibrillators held the largest share in this market segment followed by subcutaneous implantable cardioverter defibrillators. The neurostimulators market is anticipated to witness the highest growth rate during the forecast period. The demand for neurostimulators, especially deep brain stimulators is growing significantly across the globe. An increase in the prevalence of chronic pain, such as neuropathic pain, pain due to diabetes, arthritis pain and pain from injury has increased the demand for neurostimulators significantly.

Inquiry before buying @ http://www.marketdataforecast.com/market-reports/active-implantable-medical-devices-market-5027/inquire

Geographical Overview:
On the basis of geography, the market is analyzed under various regions namely North America, Europe, Asia-Pacific and Middle East and Africa. North America held the largest share in the regional segment of the market. The large share of this regional segment can be attributed to the growth in geriatric population, increase in the prevalence of cardiovascular and neurological diseases, high accessibility to advanced technologies, increase in the development of innovative and technologically advanced products, and increase in the healthcare expenditure in the region. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, due to the rise in geriatric population, growth in the occurrence of chronic diseases, rise in healthcare spending, healthcare reforms for infrastructural development, growth in the demand for advanced technologies to develop advanced products, and less strict regulations.

Key Players:
Some of the key players dominating the active implantable medical devices market include Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC., Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S and Nurotron Biotechnology Co. Ltd.

Request for discount @ http://www.marketdataforecast.com/market-reports/active-implantable-medical-devices-market-5027/request-discount

About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Media Contact:
Abhishek Shukla
International Business Development Manager
Market Data Forecast
Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release USD 26.78 billion worth is expected for Active Implantable Medical Devices Market by 2021 here

News-ID: 836638 • Views: 159

More Releases from MDF

Beta-Glucan Market will grow at a CAGR of 7.32% during 2016 to 2021
The Global Beta-Glucan Market was worth USD 328.5 million in 2016 and estimated to be growing at a CAGR of 7.32%, to reach USD 467.67 million by 2021, According to a recent report published by Market Data Forecast. Check Report Details @ https://www.marketdataforecast.com/market-reports/global-beta-glucan-market-2395/ Market Overview: Increasing demand for processed and ready to eat food coupled with rising awareness about the nutritional value of functional food is expected to be the primary driver
Agrochemical Intermediates Market Outlook 2021 | Market Data Forecast
The Global Agrochemical Intermediates Market was worth USD XX.XX billion in 2016 and estimated to be growing at a CAGR of X.XX%, to reach USD XX.XX billion by 2021. Browse details of 185 pages research report on Global Agrochemical Intermediates Market @ http://www.marketdataforecast.com/market-reports/agrochemical-intermediates-market-4802/ Agrochemical Intermediates are widely used to manufacture pesticides such as insecticides, herbicides and fungicides. Common examples of agrochemical intermediates are 2-Chloro-5-Chloro Methyl Pyridine, Diethyl Phosphorochloridothionate, 2-Chloropropionic Acid,
A Glance at the new trends in the Active, Smart and Intelligent Packaging Indust …
Perspective is important, what one person might see as utility another sees as an opportunity. Having a personal tomato patch is quite different than farming tomatoes on land the size of Vatican, even though it gives out the same product, their number varies exponentially, the thought that is put into also varies widely, and at every step of the process there are different variables to take care of. This is
11-29-2017 | Health & Medicine
MDF
6.5% is an estimated growing CAGR for Vascular Imaging Market during 2016 to 202 …
According to the Global Vascular Imaging Market Research Report, the market is anticipated to grow at a 6.5% CAGR from 2016 to 2021 and it is estimated that the global market was valued at USD 4.35 billion in 2016 and is expected to reach USD 5.96 billion by 2021. Browse details of 175 pages research report on Global Vascular Imaging Market @ http://www.marketdataforecast.com/market-reports/vascular-imaging-market-5019/ Vascular imaging tests are used to assess how

All 5 Releases


More Releases for Implantable

Implantable Hearing Devices Market - Forecast to 2026
As per the research conducted by GME, the Implantable Hearing Devices Market will grow with a high CAGR value over the forecast period. Browse TOC on “Global Implantable Hearing DevicesMarket - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-implantable-hearing-devices-market-3010 By Product (Active Hearing Implants, Passive Hearing Implants), By Type (Cochlear Implants, Middle Ear Implants, Bone Conduction Implants, Auditory Brainstem Implant), By Patient Type (Adult, Paediatric), By End-Use (Hospitals, ENT, Ambulatory Surgical Centres), By Region (North America,
Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025. For In depth Information Get
Implantable Ports Market - Competition Framework 2017-2025
Global Implantable Ports Market: Overview Implantable ports, which are long, narrow, soft, and thin plastic tubes with a rubber disc at the end, are frequently inserted into chemotherapy patients in order to administrate drugs to individuals. Also called as portacaths or subcutaneous, the diameter of implantable ports ranges from 2.5 cm to 4 cm and are highly useful for patients receiving treatment into a vein. Blood transfusions, chemotherapy, intravenous (IV) fluids,
Implantable Ports Market Sharp Rise over 2025
Global Implantable Ports Market: Overview Implantable ports, which are long, narrow, soft, and thin plastic tubes with a rubber disc at the end, are frequently inserted into chemotherapy patients in order to administrate drugs to individuals. Also called as portacaths or subcutaneous, the diameter of implantable ports ranges from 2.5 cm to 4 cm and are highly useful for patients receiving treatment into a vein. Blood transfusions, chemotherapy, intravenous (IV) fluids,
Implantable Medical Devices Market: A comprehensive survey
The global market for implantable medical devices market is experiencing an increased demand due to rampant technological advancements. The market is highly consolidated as the top four players account for a little over 50% of the market share making it difficult for new players to enter the market. Moreover, the research excellence attained by these established players overpowers the ability of other small and medium sized players to innovate and
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of